Mm. Graham et al., 1-[CARBON-11]-GLUCOSE RADIATION-DOSIMETRY AND DISTRIBUTION IN HUMAN IMAGING STUDIES, The Journal of nuclear medicine, 39(10), 1998, pp. 1805-1810
l-[Carbon-11]-D-glucose ([C-11]-glucose) is an important imaging agent
for PET studies that have been used to study the normal brain, enceph
alitis, epilepsy, manic-depressive disorder, schizophrenia and brain t
umors. Methods: Dosimetry estimates were calculated in subjects underg
oing imaging studies to help define the radiation risk of [(11C)]-gluc
ose PET imaging. Time-dependent radioactivity concentrations in normal
tissues in 33 subjects after intravenous injection of [C-11]-glucose
were obtained by PET imaging. Radiation absorbed doses were calculated
according to the procedures of the Medical Internal Radiation Dose (M
IRD) committee along with the variation in dose based on the calculate
d standard deviation of activity distribution seen in the individual p
atients. Results: Total body exposure was a median of 3.0 mu Gy/MBq in
men and 3.8 mu Gy/MBq in women. The effective dose equivalent was 3.8
mu Gy/MBq in men and 4.8 mu Gy/MBq in women. The critical organs were
those that typically take up the most glucose (brain, heart wall and
liver). Conclusion: The organ doses reported here are small and compar
able to those associated with other commonly performed nuclear medicin
e tests and indicate that potential radiation risks associated with th
is radiotracer are within generally accepted limits.